Personal Health Train for Radiation Oncology in India and The Netherlands

The primary and general objective of this protocol as the current standard of care is to improve the quality of radiotherapy for HNC patients. This will ultimately be achieved by optimizing locoregional tumour control and overall survival and by reducing radiation-induced side effects. It will also allow the assessment of the effects of newly introduced radiation technology (e.g. proton therapy) for this particular group of patients. The clinical introduction of this standard follow-up program (SFP) will allow for a systematic and broad scale quality improvement cycle for HNC patients treated with radiotherapy.

NCT Number	NCT04655469
Lead Sponsor	Maastricht Radiation Oncology
Conditions	Head and Neck Carcinoma
Enrollment	2,000 participants
Start Date	2020-04-10
Primary Completion	2024-05-15 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-22